Argan Gemma CEO sells shares after option exercises
ARGAN INC executive Charles Edwin Collins IV, CEO of Gemma, reported option exercises and share sales in April 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ARGAN INC executive Charles Edwin Collins IV, CEO of Gemma, reported option exercises and share sales in April 2026. He exercised stock options to acquire a total of 13,568 shares of common stock at exercise prices ranging from $33.81 to $148.72 per share.
On April 20, 2026, he exercised an option for 2,500 shares at $39.47 per share and sold 2,500 shares at $610 per share. On April 21, 2026, he exercised additional options totaling 11,068 shares and sold 11,068 shares at an average price of $621.61 per share. Following these transactions, he directly holds 30,320 shares of ARGAN common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock | 5,000 | $36.78 | $184K |
| Exercise | Option to Purchase Common Stock | 5,235 | $33.81 | $177K |
| Exercise | Option to Purchase Common Stock | 500 | $61.22 | $31K |
| Exercise | Option to Purchase Common Stock | 333 | $148.72 | $50K |
| Exercise | Common Stock | 5,000 | $36.78 | $184K |
| Exercise | Common Stock | 5,235 | $33.81 | $177K |
| Exercise | Common Stock | 500 | $61.22 | $31K |
| Exercise | Common Stock | 333 | $148.72 | $50K |
| Sale | Common Stock | 11,068 | $621.61 | $6.88M |
| Exercise | Option to Purchase Common Stock | 2,500 | $39.47 | $99K |
| Exercise | Common Stock | 2,500 | $39.47 | $99K |
| Sale | Common Stock | 2,500 | $610.00 | $1.52M |
Footnotes (7)
- F1. On April 20, 2026, the Reporting Person exercised his stock option awarded on April 17, 2023 to purchase 2,500 shares of the Issuer's common stock at a price of $39.47 per share.
- F2. On April 20, 2026, the Reporting Person sold 2,500 shares of the Issuer's common stock on the open market at a price of $610 per share.
- F3. On April 21, 2026, the Reporting Person exercised his stock option awarded on April 18, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $36.78 per share.
- F4. On April 21, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 16, 2020 to purchase 5,235 shares of the Issuer's common stock at a price of $33.81 per share.
- F5. On April 21, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 500 shares of the Issuer's common stock at a price of $61.22 per share.
- F6. On April 21, 2026, the Reporting Person exercised a portion of his stock option awarded on April 10, 2025 to purchase 333 shares of the Issuer's common stock at a price of $148.72 per share.
- F7. On April 21, 2026, the Reporting Person sold 11,068 shares of the Issuer's common stock on the open market at an average price of $621.61 per share.
Key Figures
Key Terms
open-market sale financial
stock option financial
derivative security financial
Option to Purchase Common Stock financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did AGX executive Charles Edwin Collins IV report?
What stock options did Collins exercise in this Form 4 for AGX?
What is the overall pattern of Collins’ April 2026 AGX trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.